Patent · US Expired

Pharmaceutical compositions comprising TGF-beta

US6649168B2 · kind B2 · utility

14Cited by

23References

5Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Tudor Arvinte · Riehen, CH
Uwe Thomas Schote · Basel, CH
Juergen Sigg · Soest, DE

Key dates

Filing date	Sep 17, 2001
Grant date	Nov 18, 2003
Priority date	—
Expiry date	Sep 17, 2021

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61L2300/802
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention provides pharmaceutical compositions comprising TGF-&bgr;.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.